Found: 13
Select item for more details and to access through your institution.
Ex vivo characterization of acute myeloid leukemia patients undergoing hypomethylating agents and venetoclax regimen reveals a venetoclax-specific effect on non-suppressive regulatory T cells and bona fide PD-1<sup>+</sup>TIM3<sup>+</sup> exhausted CD8<sup>+</sup> T cells.
- Published in:
- Frontiers in Immunology, 2024, p. 01, doi. 10.3389/fimmu.2024.1386517
- By:
- Publication type:
- Article
Exploring the ATR-CHK1 pathway in the response of doxorubicin-induced DNA damages in acute lymphoblastic leukemia cells.
- Published in:
- Cell Biology & Toxicology, 2023, v. 39, n. 3, p. 795, doi. 10.1007/s10565-021-09640-x
- By:
- Publication type:
- Article
Circulating cell‐free DNA for target quantification in hematologic malignancies: Validation of a protocol to overcome pre‐analytical biases.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 1, p. 50, doi. 10.1002/hon.3087
- By:
- Publication type:
- Article
Baseline cluster of differentiation 22 fluorescent intensity correlates with patient outcome after Inotuzumab Ozogamicin treatment.
- Published in:
- Hematological Oncology, 2022, v. 40, n. 4, p. 734, doi. 10.1002/hon.3029
- By:
- Publication type:
- Article
Inotuzumab ozogamicin and donor lymphocyte infusion is a safe and promising combination in relapsed acute lymphoblastic leukemia after allogeneic stem cell transplant.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 4, p. 580, doi. 10.1002/hon.2886
- By:
- Publication type:
- Article
Case Report: A Novel Activating FLT3 Mutation in Acute Myeloid Leukemia.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.728613
- By:
- Publication type:
- Article
Adrenomedullin Expression Characterizes Leukemia Stem Cells and Associates With an Inflammatory Signature in Acute Myeloid Leukemia.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.684396
- By:
- Publication type:
- Article
Synergism Through WEE1 and CHK1 Inhibition in Acute Lymphoblastic Leukemia.
- Published in:
- Cancers, 2019, v. 11, n. 11, p. 1654, doi. 10.3390/cancers11111654
- By:
- Publication type:
- Article
Identification of Two DNMT3A Mutations Compromising Protein Stability and Methylation Capacity in Acute Myeloid Leukemia.
- Published in:
- Journal of Oncology, 2019, p. 1, doi. 10.1155/2019/5985923
- By:
- Publication type:
- Article
Inotuzumab ozogamicin is effective in relapsed/refractory extramedullary B acute lymphoblastic leukemia.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Age, Disease Status before Blinatumomab, MRD Negativity Obtainment, and Bridge to Transplant Influence Outcome in Patients with B-ALL: A Single Center Experience.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S181, doi. 10.1016/j.clml.2018.07.011
- By:
- Publication type:
- Article
Targeting WEE1 to enhance conventional therapies for acute lymphoblastic leukemia.
- Published in:
- Journal of Hematology & Oncology, 2018, v. 11, n. 1, p. N.PAG, doi. 10.1186/s13045-018-0641-1
- By:
- Publication type:
- Article
Blinatumomab is Safe and Effective in Relapsed and MRD Positive B-ALL CD19+ Patients: the Bologna Compassionate Program Experience.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2016, v. 16, p. S14, doi. 10.1016/j.clml.2016.07.022
- By:
- Publication type:
- Article